newsfilter
← Latest News
GlobeNewswire·

Vivos Therapeutics Schedules Release of Second Quarter 2025 Financial Results and Conference Call

LITTLETON, Colo., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and